Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Lung Cancer (Amsterdam, Netherlands)|June 2, 2026
Real-world comparative effectiveness of sotorasib versus docetaxel monotherapy in second line and beyond for advanced or metastatic non-small cell lung cancer: A national database analysis from EnglandNadia Karim, Kellyn Arnold, Yvonne Summers, et al.
Data in Brief|June 25, 2021
Real-world progression-free survival in first-line advanced non-small cell lung cancer treated with immunotherapy-based regimens using a US datasetDavid Waterhouse, Jenny Lam, Keith A Betts, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2018
Intra-individual effects of food upon the pharmacokinetics of rifampicin and isoniazidAna Requena-Méndez, Geraint Davies, David Waterhouse, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Effects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patientsAna Requena-Méndez, Geraint Davies, David Waterhouse, et al.
Breast Cancer Research and Treatment|November 21, 2013
Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancerDenise A Yardley, Lowell Hart, David Waterhouse, et al.
Cancer Investigation|April 30, 2016
A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine CancersJohanna C Bendell, Ahmed Zakari, Evan Lang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2009
Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology GroupShadia Jalal, David Waterhouse, Martin J Edelman, et al.
The Oncologist|February 26, 2016
A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases OnlyJohanna C Bendell, Ahmed Zakari, James D Peyton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75Noah M Hahn, Walter M Stadler, Robin T Zon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 9, 2018
Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation - Positive Advanced Non-Small Cell Lung Cancer (CheckMate 370)David R Spigel, Craig Reynolds, David Waterhouse, et al.
Pageof 7